Scientist in South Africa says Omicron "may have" peaked in Johannesburg
Dr. Tulio Oliveira, who leads the team that first reported the Omicron variant, says it "may have" reached its peak in Johannesburg.
Watch CBS News
Dr. Tulio Oliveira, who leads the team that first reported the Omicron variant, says it "may have" reached its peak in Johannesburg.
Missed the second half of the show? The latest on a winter COVID surge in New Hampshire, the Federal Reserve's failure to curb inflation, and Johannesburg's battle with the Omicron variant.
The Omicron variant has been detected in dozens of states across the U.S., but CBS News national correspondent Mark Strassmann reports on a new CBS News poll that indicates its spread is not deterring Americans from gathering this holiday season. Then, CBSN's Lana Zak sits down with CBS News reporter and researcher Max Bayer to discuss the latest on the Omicron variant.
CBS News’ Elizabeth Palmer reports 35 million COVID-19 vaccine doses are administered worldwide every day, but it's a long way from enough to end the pandemic.
People who are vaccinated call for requirements on planes, public places.
The U.S. is experiencing a COVID-19 resurgence as new cases increased 37% nationwide this week. Some 40% of Americans remain unvaccinated. Michael George reports.
Saturday marks one year since the Food and Drug Administration authorized Pfizer's COVID-19 vaccine.
The U.S. is once again tackling an alarming surge in coronavirus infections. CBS News correspondent Nikki Battiste reports from Connecticut where hospitalizations have soared nearly 82% over the past two weeks. Then, Dr. Andre Campbell, a critical care physician and a professor at the University of California at San Francisco, joins CBSN's Lana Zak to discuss the latest.
The measure is effective starting on Monday until January 15.
The FDA authorized booster shots of the Pfizer COVID-19 vaccine for Americans as young as 16 on Thursday. The move comes as the Delta variant continues to drive an increase in cases and hospitalizations across the country. CBS News correspondent Nikki Battiste reports on the recent surge in cases in several U.S. states. Then, emergency medicine physician Dr. Anand Swaminathan joins CBSN's Lana Zak to discuss the latest.
Some teenagers may soon be eligible for COVID-19 vaccine booster shots. This news comes after Pfizer revealed that three doses of its vaccine are more effective at neutralizing the Omicron variant than two. Dr. Esther Choo, professor of emergency medicine at Oregon Health and Sciences University, joins CBSN to discuss some of the latest coronavirus headlines.
The latest wave of COVID-19 infections is leading to more hospitalizations and deaths in the U.S., and there are rising concerns about the emerging Omicron variant. CBS news correspondents Nikki Battiste and Debora Patta report from New York City and South Africa. Then, University of Virginia critical care and infectious disease physician and medical ICU director Dr. Taison Bell joins CBSN's Lana Zak to discuss the latest coronavirus news.
Scandal over an apparent party at PM Boris Johnson's own house, of which he denies any knowledge, shakes trust in the government as the U.K. grapples with rising Omicron cases.
South Africa's fourth COVID wave looks nothing like the previous three. Despite soaring infections, hospitals there are not overflowing with patients. Debora Patta takes a look.
Pfizer said early research found that two shots of its COVID vaccine appear to be much less effective against Omicron than previous variants, but a booster offers significantly more protection. Nikki Battiste has the latest.
A preliminary study from Pfizer and BioNTech suggest that a booster shot might be the best way to combat Omicron.
Pfizer and BioNTech say a third dose of their COVID-19 vaccine is needed to fully protect against the Omicron variant. Recent studies show two doses of the shot are "significantly less effective at blocking the virus." John Moore, professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero to discuss the new variant and the latest vaccine information.
Pfizer says preliminary research shows that a booster dose of its existing COVID-19 vaccine raises effectiveness when battling the Omicron variant. CBS News' Laura Podesta joins "CBSN AM" with more.
The new COVID-19 strain is on a list of words that have proved most challenging for newsreaders and people on TV to pronounce.
While it appears that Omicron has a "very large" advantage over previous strains, it doesn't appear to be making people sicker, and Pfizer says a booster shot "neutralized" it in the lab.
The list identifies words that proved most challenging for newsreaders and people on television to pronounce this year.
As concerns over the new Omicron variant grow, public health experts say the Delta variant is still causing a majority of infections in the U.S. CBS News correspondent Nikki Battiste reports Omicron may cause less serious illness than other variants. Then, ER physician and Harvard Medical School professor Dr. Ali Raja joins CBSN's Elaine Quijano for the latest on COVID-19.
New York City Mayor Bill de Blasio is setting new vaccine deadlines for private sector employees who work in-person, and children ages 5 to 11 who want to participate in certain indoor activities. Dr. Dyan Hes, founder of Gramercy Pediatrics. joins CBSN to discuss the latest coronavirus headlines.
Pfizer's COVID-19 vaccine offers some protection against the Omicron variant "but not complete" protection, according to an early study by South African scientists. Nikki Battiste shares the latest.
The new testing rules come as coronavirus cases rise ahead of the holidays. In the U.S., officials are reporting more than 100,000 new infections a day for the first time since early October.